{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:59:27Z","timestamp":1794434367543,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10067-022-06364-z","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T18:21:53Z","timestamp":1662747713000},"page":"3887-3896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma"],"prefix":"10.1007","volume":"41","author":[{"given":"Thanika","family":"Ketpueak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanitcha","family":"Chanloung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittiya Na","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chontara","family":"Pongsananurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuntana","family":"Kasitanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3105-6122","authenticated-orcid":false,"given":"Worawit","family":"Louthrenoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"issue":"4","key":"6364_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0305-7372(93)90010-o","volume":"19","author":"R Pazdur","year":"1993","unstructured":"Pazdur R, Kudelka AP, Kavanagh JJ, Cohen PR, Raber MN (1993) The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere). Cancer Treat Rev 19(4):351\u2013386. https:\/\/doi.org\/10.1016\/0305-7372(93)90010-o","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"6364_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1684\/ejd.2016.2833","volume":"26","author":"V Sibaud","year":"2016","unstructured":"Sibaud V, Leboeuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME (2016) Dermatological adverse events with taxane chemotherapy. Eur J Dermatol 26(5):427\u2013443. https:\/\/doi.org\/10.1684\/ejd.2016.2833","journal-title":"Eur J Dermatol"},{"issue":"1","key":"6364_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/1097-0142(19950701)76:1<110::aid-cncr2820760117>3.0.co;2-9","volume":"76","author":"DF Battafarano","year":"1995","unstructured":"Battafarano DF, Zimmerman GC, Older SA, Keeling JH, Burris HA (1995) Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases Cancer 76(1):110\u2013115. https:\/\/doi.org\/10.1002\/1097-0142(19950701)76:1%3c110::aid-cncr2820760117%3e3.0.co;2-9","journal-title":"A report of three cases Cancer"},{"issue":"1","key":"6364_CR4","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.4081\/dr.2010.e9","volume":"2","author":"SM Bouchard","year":"2010","unstructured":"Bouchard SM, Mohr MR, Pariser RJ (2010) Taxane-induced morphea in a patient with CREST syndrome. Dermatol Reports 2(1):e9. https:\/\/doi.org\/10.4081\/dr.2010.e9","journal-title":"Dermatol Reports"},{"issue":"5","key":"6364_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1078::AID-CNCR19>3.0.CO;2-T","volume":"88","author":"MG Cleveland","year":"2000","unstructured":"Cleveland MG, Ajaikumar BS, Reganti R (2000) Cutaneous fibrosis induced by docetaxel: a case report. Cancer 88(5):1078\u20131081","journal-title":"Cancer"},{"issue":"1","key":"6364_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10067-002-0635-8","volume":"22","author":"R De Angelis","year":"2003","unstructured":"De Angelis R, Bugatti L, Cerioni A, Del Medico P, Filosa G (2003) Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer. Clin Rheumatol 22(1):49\u201352. https:\/\/doi.org\/10.1007\/s10067-002-0635-8","journal-title":"Clin Rheumatol"},{"issue":"1","key":"6364_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archdermatol.2008.532","volume":"145","author":"T Kawakami","year":"2009","unstructured":"Kawakami T, Tsutsumi Y, Soma Y (2009) Limited cutaneous systemic sclerosis induced by paclitaxel in a patient with breast cancer. Arch Dermatol 145(1):97\u201398. https:\/\/doi.org\/10.1001\/archdermatol.2008.532","journal-title":"Arch Dermatol"},{"issue":"2","key":"6364_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5152\/tjbh.2015.1879","volume":"11","author":"MO Kilic","year":"2015","unstructured":"Kilic MO, Yalaza M, Bilgic CI, Dener C (2015) Docetaxel-induced scleroderma in a breast cancer patient: a case report. J Breast Health 11(2):95\u201397. https:\/\/doi.org\/10.5152\/tjbh.2015.1879","journal-title":"J Breast Health"},{"issue":"2","key":"6364_CR9","first-page":"197","volume":"19","author":"G Hassett","year":"2001","unstructured":"Hassett G, Harnett P, Manolios N (2001) Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 19(2):197\u2013200","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"6364_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2230.2004.01519.x","volume":"29","author":"PB Farrant","year":"2004","unstructured":"Farrant PB, Mortimer PS, Gore M (2004) Scleroderma and the taxanes. Is there really a link? Clin Exp Dermatol 29(4):360\u2013362. https:\/\/doi.org\/10.1111\/j.1365-2230.2004.01519.x","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"6364_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2133.2006.07597.x","volume":"156","author":"M Itoh","year":"2007","unstructured":"Itoh M, Yanaba K, Kobayashi T, Nakagawa H (2007) Taxane-induced scleroderma. Br J Dermatol 156(2):363\u2013367. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07597.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"6364_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1067\/mjd.2003.30","volume":"48","author":"I Kupfer","year":"2003","unstructured":"Kupfer I, Balguerie X, Courville P, Chinet P, Joly P (2003) Scleroderma-like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol 48(2):279\u2013281. https:\/\/doi.org\/10.1067\/mjd.2003.30","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"6364_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1046\/j.1365-2133.2002.488210.x","volume":"147","author":"S Lauchli","year":"2002","unstructured":"Lauchli S, Trueb RM, Fehr M, Hafner J (2002) Scleroderma-like drug reaction to paclitaxel (Taxol). Br J Dermatol 147(3):619\u2013621. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.488210.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"6364_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000503271","volume":"11","author":"SI Motegi","year":"2019","unstructured":"Motegi SI, Ishikawa M, Sekiguchi A, Ishikawa O (2019) Nanoparticle albumin-bound paclitaxel- and\/or gemcitabine-induced scleroderma accompanied by acanthosis nigricans-like skin changes. Case Rep Dermatol 11(3):273\u2013277. https:\/\/doi.org\/10.1159\/000503271","journal-title":"Case Rep Dermatol"},{"issue":"4","key":"6364_CR15","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1111\/1346-8138.13569","volume":"44","author":"T Ogawa","year":"2017","unstructured":"Ogawa T, Okiyama N, Koguchi-Yoshioka H, Fujimoto M (2017) Taxane-induced scleroderma-like skin changes resulting in gangrene: a case report. J Dermatol 44(4):e54\u2013e55. https:\/\/doi.org\/10.1111\/1346-8138.13569","journal-title":"J Dermatol"},{"issue":"12","key":"6364_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/1346-8138.13085","volume":"42","author":"A Ohashi","year":"2015","unstructured":"Ohashi A, Minagawa A, Ashida A, Koga H, Uhara H, Okuyama R (2015) Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer. J Dermatol 42(12):1198\u20131199. https:\/\/doi.org\/10.1111\/1346-8138.13085","journal-title":"J Dermatol"},{"issue":"4","key":"6364_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/bjd.13899","volume":"173","author":"K Okada","year":"2015","unstructured":"Okada K, Endo Y, Miyachi Y, Koike Y, Kuwatsuka Y, Utani A (2015) Glycosaminoglycan and versican deposits in taxane-induced sclerosis. Br J Dermatol 173(4):1054\u20131058. https:\/\/doi.org\/10.1111\/bjd.13899","journal-title":"Br J Dermatol"},{"issue":"6","key":"6364_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3109\/02841861003702510","volume":"49","author":"JV Pedersen","year":"2010","unstructured":"Pedersen JV, Jensen S, Krarup-Hansen A, Riis L (2010) Scleroderma induced by paclitaxel. Acta Oncol 49(6):866\u2013868. https:\/\/doi.org\/10.3109\/02841861003702510","journal-title":"Acta Oncol"},{"issue":"3","key":"6364_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1684\/ejd.2016.2763","volume":"26","author":"K Shibao","year":"2016","unstructured":"Shibao K, Okiyama N, Maruyama H, Jun-Ichi F, Fujimoto M (2016) Scleroderma-like skin changes occurring after the use of paclitaxel without any chemical solvents: a first case report. Eur J Dermatol 26(3):317\u2013318. https:\/\/doi.org\/10.1684\/ejd.2016.2763","journal-title":"Eur J Dermatol"},{"issue":"6","key":"6364_CR20","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1365-2133.2011.10243.x","volume":"164","author":"T Takahashi","year":"2011","unstructured":"Takahashi T, Asano Y, Ichimura Y, Taniguchi T, Kogure A, Tamaki Z, Takekoshi T, Sugaya M, Sato S (2011) A case of taxane-induced scleroderma: a different expression profile of Fli1 proteins in dermal fibroblasts and microvascular endothelial cells compared with systemic sclerosis. Br J Dermatol 164(6):1393\u20131395. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10243.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"6364_CR21","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1111\/ajd.12719","volume":"59","author":"N Tani","year":"2018","unstructured":"Tani N, Sugita K, Yamamoto O (2018) Paclitaxel-related scleredema-like skin changes in a patient with breast cancer. Australas J Dermatol 59(3):e215\u2013e217. https:\/\/doi.org\/10.1111\/ajd.12719","journal-title":"Australas J Dermatol"},{"issue":"1","key":"6364_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/ijd.12437","volume":"55","author":"RR Winkelmann","year":"2016","unstructured":"Winkelmann RR, Yiannias JA, DiCaudo DJ, Trotter SC, Farhey Y, Griffing WL, Martorano LM, Winkelmann JC (2016) Paclitaxel-induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud\u2019s phenomenon, and myositis. Int J Dermatol 55(1):97\u2013100. https:\/\/doi.org\/10.1111\/ijd.12437","journal-title":"Int J Dermatol"},{"issue":"3","key":"6364_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1447-0756.2010.01171.x","volume":"36","author":"Y Konishi","year":"2010","unstructured":"Konishi Y, Sato H, Sato N, Fujimoto T, Fukuda J, Tanaka T (2010) Scleroderma-like cutaneous lesions induced by paclitaxel and carboplatin for ovarian carcinoma, not a single course of carboplatin, but re-induced and worsened by previously administrated paclitaxel. J Obstet Gynaecol Res 36(3):693\u2013696. https:\/\/doi.org\/10.1111\/j.1447-0756.2010.01171.x","journal-title":"J Obstet Gynaecol Res"},{"issue":"9","key":"6364_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/ijd.14067","volume":"57","author":"L Verhulst","year":"2018","unstructured":"Verhulst L, Noe E, Morren MA, Verslype C, Van Cutsem E, Van den Oord JJ, De Haes P (2018) Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature Int J Dermatol 57(9):1075\u20131079. https:\/\/doi.org\/10.1111\/ijd.14067","journal-title":"Review of literature Int J Dermatol"},{"issue":"5","key":"6364_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4067\/s0034-98872021000500807","volume":"149","author":"J Cury-Martins","year":"2021","unstructured":"Cury-Martins J, Giesen L, Gonzalez S, Molgo M, Sanches JA (2021) Taxane-induced scleroderma. Report of two cases. Rev Med Chil 149(5):807\u2013809. https:\/\/doi.org\/10.4067\/s0034-98872021000500807","journal-title":"Rev Med Chil"},{"issue":"11","key":"6364_CR26","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1111\/1756-185X.12697","volume":"20","author":"JQ Yang","year":"2017","unstructured":"Yang JQ, Dou TT, Chen XB, Min M, Cai SQ, Zheng M, Man XY (2017) Docetaxel-induced scleroderma: a case report and its role in the production of extracellular matrix. Int J Rheum Dis 20(11):1835\u20131837. https:\/\/doi.org\/10.1111\/1756-185X.12697","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"6364_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/23971983211007669","volume":"6","author":"V Debien","year":"2021","unstructured":"Debien V, Petitdemange A, Bazin D, Ederle C, Nespola B, Merdji H, Olagne J, Martin T, Guffroy A, Pflumio C (2021) New-onset systemic sclerosis and scleroderma renal crisis under docetaxel. J Scleroderma Relat Disord 6(3):306\u2013310. https:\/\/doi.org\/10.1177\/23971983211007669","journal-title":"J Scleroderma Relat Disord"},{"issue":"9","key":"6364_CR28","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","volume":"41","author":"VD Steen","year":"1998","unstructured":"Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41(9):1613\u20131619. https:\/\/doi.org\/10.1002\/1529-0131(199809)41:9%3c1613::AID-ART11%3e3.0.CO;2-O","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6364_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneph.2017.183","volume":"14","author":"TG Woodworth","year":"2018","unstructured":"Woodworth TG, Suliman YA, Li W, Furst DE, Clements P (2018) Scleroderma renal crisis and renal involvement in systemic sclerosis. Nat Rev Nephrol 14(2):137. https:\/\/doi.org\/10.1038\/nrneph.2017.183","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"6364_CR30","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3899\/jrheum.080806","volume":"36","author":"V Codullo","year":"2009","unstructured":"Codullo V, Cavazzana I, Bonino C, Alpini C, Cavagna L, Cozzi F, Del Papa N, Franceschini F, Guiducci S, Morozzi G, Ruffatti A, Ferri C, Giacomelli R, Matucci-Cerinic M, Valentini G, Montecucco C (2009) Serologic profile and mortality rates of scleroderma renal crisis in Italy. J Rheumatol 36(7):1464\u20131469. https:\/\/doi.org\/10.3899\/jrheum.080806","journal-title":"J Rheumatol"},{"issue":"5","key":"6364_CR31","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3899\/jrheum.091048","volume":"37","author":"B Nguyen","year":"2010","unstructured":"Nguyen B, Assassi S, Arnett FC, Mayes MD (2010) Association of RNA polymerase antibodies with scleroderma renal crisis. J Rheumatol 37(5):1068\u20131069. https:\/\/doi.org\/10.3899\/jrheum.091048 (author reply)","journal-title":"J Rheumatol"},{"issue":"2","key":"6364_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/art.38219","volume":"66","author":"V Sobanski","year":"2014","unstructured":"Sobanski V, Dauchet L, Lefevre G, Lambert M, Morell-Dubois S, Sy T, Hachulla E, Hatron PY, Launay D, Dubucquoi S (2014) Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: new data from a French cohort and a systematic review and meta-analysis. Arthritis Rheumatol 66(2):407\u2013417. https:\/\/doi.org\/10.1002\/art.38219","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"6364_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.bjc.6600347","volume":"87","author":"N Tsavaris","year":"2002","unstructured":"Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D (2002) Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 87(1):21\u201327. https:\/\/doi.org\/10.1038\/sj.bjc.6600347","journal-title":"Br J Cancer"},{"issue":"12","key":"6364_CR34","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1371\/journal.pmed.0020354","volume":"2","author":"X Liu","year":"2005","unstructured":"Liu X, Zhu S, Wang T, Hummers L, Wigley FM, Goldschmidt-Clermont PJ, Dong C (2005) Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice. PLoS Med 2(12):e354. https:\/\/doi.org\/10.1371\/journal.pmed.0020354","journal-title":"PLoS Med"},{"issue":"5","key":"6364_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00281-015-0511-7","volume":"37","author":"J Raja","year":"2015","unstructured":"Raja J, Denton CP (2015) Cytokines in the immunopathology of systemic sclerosis. Semin Immunopathol 37(5):543\u2013557. https:\/\/doi.org\/10.1007\/s00281-015-0511-7","journal-title":"Semin Immunopathol"},{"issue":"10103","key":"6364_CR36","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06364-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:35:16Z","timestamp":1744205716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06364-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6364"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06364-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"assertion":[{"value":"27 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Faculty of Medicine, Chiang Mai University (no. 8839\/2022). It was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Written informed consent for data collection and publication was obtained from the patient\u2019s daughter.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publish"}},{"value":"The authors of this work have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}